IYH icon

iShares US Healthcare ETF

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 44.4%
Negative

Neutral
Seeking Alpha
1 month ago
Medical Technology Stocks: Innovation Endures As Valuations Reset
Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.
Medical Technology Stocks: Innovation Endures As Valuations Reset
Positive
Zacks Investment Research
1 month ago
Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch
Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.
Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch
Positive
Seeking Alpha
1 month ago
Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit
Recent White House and FDA actions fast-track psychedelic depression drug approvals, granting priority review vouchers and accelerating rescheduling for eligible therapies. Compass Pathways leads with a CNPV for COMP360 in treatment-resistant depression, positive Phase 3 data, and a sub-$1bn market cap suggesting potential upside.
Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit
Neutral
Zacks Investment Research
1 month ago
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Launched on June 12, 2000, the iShares U.S. Healthcare ETF (IYH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Positive
ETF Trends
1 month ago
What Johnson & Johnson Earnings Signal for Healthcare ETFs
With Q1 earnings season well underway, it was Johnson & Johnson (JNJ) giving investors a peek at how the broader healthcare sector might perform. The healthcare giant beat expectations on Tuesday in revenue ($24.1 billion actual versus $23.6 expected) and earnings per share ($2.70 actual versus $2.66 expected).
What Johnson & Johnson Earnings Signal for Healthcare ETFs
Neutral
Seeking Alpha
1 month ago
Can Forgotten Biotech Break Out?
After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.
Can Forgotten Biotech Break Out?
Neutral
Zacks Investment Research
2 months ago
Consumer Sentiment Weakens: ETFs That Are Worth a Look
Rising oil prices and Middle East tensions are squeezing household finances and weakening consumer sentiment, steering investors toward defensive ETFs.
Consumer Sentiment Weakens: ETFs That Are Worth a Look
Negative
Zacks Investment Research
2 months ago
Stagflation Scare? ETFs May Help Protect Your Portfolio
Are stagflation risks returning as oil-driven inflation rises amid Middle East tensions? Here's how ETFs can help defend portfolios.
Stagflation Scare? ETFs May Help Protect Your Portfolio
Negative
Zacks Investment Research
2 months ago
Middle East Turmoil and U.S. Debt Surge: ETFs in Focus
With U.S. budget deficits and already elevated debt, the ongoing Middle East war could worsen the fiscal outlook, making defensive ETF strategies worth considering for stability.
Middle East Turmoil and U.S. Debt Surge: ETFs in Focus
Neutral
Zacks Investment Research
3 months ago
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Launched on June 12, 2000, the iShares U.S. Healthcare ETF (IYH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?